MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Total Assets 2011-2026 | HBIO
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.1 M | 127 M | 137 M | 145 M | 162 M | 156 M | 165 M | 169 M | 109 M | 108 M | 120 M | 136 M | 135 M | 133 M | 127 M | 125 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | 80.1 M | 133 M |
Quarterly Total Assets Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.9 M | 78 M | 80.1 M | 79.8 M | 127 M | 131 M | 129 M | 133 M | 137 M | 140 M | 143 M | 146 M | 145 M | - | - | 158 M | 162 M | 154 M | 154 M | 151 M | 156 M | 156 M | 156 M | 156 M | 165 M | 165 M | 165 M | 165 M | 169 M | 169 M | 169 M | 169 M | 109 M | 109 M | 109 M | 109 M | 108 M | 108 M | 108 M | 108 M | 120 M | 120 M | 120 M | 120 M | 136 M | 136 M | 136 M | 136 M | 135 M | 135 M | 146 M | 135 M | 133 M | 133 M | 133 M | 133 M | 127 M | 127 M | 127 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 169 M | 77.9 M | 134 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 62.02 | 2.78 % | $ 12.3 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Glaukos Corporation
GKOS
|
893 M | $ 121.69 | 7.24 % | $ 6.96 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
20.5 B | $ 418.82 | 2.83 % | $ 149 B | USA |
 |
Alcon
ALC
|
31.6 B | $ 66.58 | 3.67 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
4.05 B | $ 134.93 | 3.38 % | $ 3.32 B | USA |
 |
Repro Med Systems
KRMD
|
28.2 M | $ 4.14 | 5.61 % | $ 191 M | USA |
 |
iRhythm Technologies
IRTC
|
1.02 B | $ 107.35 | 2.67 % | $ 3.44 B | USA |
 |
LeMaitre Vascular
LMAT
|
616 M | - | - | $ 2.12 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 178.9 | 0.07 % | $ 9.54 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
81.5 M | - | - | $ 89.7 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
20.1 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
7.81 M | $ 0.43 | 11.28 % | $ 35.3 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
18.7 M | $ 9.94 | 0.81 % | $ 84.3 K | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 22.87 | 2.1 % | $ 3.84 B | USA |
 |
Haemonetics Corporation
HAE
|
2.4 B | $ 69.85 | 6.03 % | $ 3.3 B | USA |
 |
Isoray
ISR
|
267 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
10.7 B | $ 212.24 | 0.98 % | $ 20.8 B | USA |
 |
STAAR Surgical Company
STAA
|
452 M | $ 29.86 | 5.66 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
101 M | $ 9.12 | 1.0 % | $ 188 M | USA |
 |
Teleflex Incorporated
TFX
|
6.95 B | $ 132.11 | 2.76 % | $ 5.9 B | USA |
 |
Merit Medical Systems
MMSI
|
2.69 B | $ 63.04 | 3.94 % | $ 3.73 B | USA |
 |
Utah Medical Products
UTMD
|
123 M | $ 67.99 | 3.75 % | $ 220 M | USA |
 |
West Pharmaceutical Services
WST
|
4.27 B | $ 317.32 | 0.32 % | $ 22.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.43 B | $ 9.88 | 2.49 % | $ 1.97 B | USA |
 |
Pulse Biosciences
PLSE
|
94.5 M | $ 26.94 | 7.8 % | $ 1.82 B | USA |
 |
Retractable Technologies
RVP
|
143 M | $ 0.66 | 0.41 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 67.0 | 2.81 % | $ 220 M | USA |
 |
Predictive Oncology
POAI
|
52.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
406 M | - | - | $ 1.29 B | USA |
 |
Stereotaxis
STXS
|
52.3 M | $ 1.88 | 2.17 % | $ 171 M | USA |
 |
Baxter International
BAX
|
20.1 B | $ 19.35 | 4.31 % | $ 9.93 B | USA |
 |
ResMed
RMD
|
5.1 B | $ 194.32 | 4.2 % | $ 28.4 B | USA |
 |
AtriCure
ATRC
|
654 M | - | - | $ 1.3 B | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 12.03 | 7.41 % | $ 491 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 149.56 | 2.73 % | $ 43 B | USA |
 |
Nephros
NEPH
|
13.6 M | $ 3.59 | -1.37 % | $ 38.1 M | USA |
 |
OraSure Technologies
OSUR
|
403 M | $ 4.17 | 5.57 % | $ 306 M | USA |
 |
Repligen Corporation
RGEN
|
2.95 B | $ 126.55 | 3.96 % | $ 7.12 M | USA |